SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-23-000322
Filing Date
2023-01-03
Accepted
2023-01-03 09:09:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A d403208dsc14d9a.htm SC 14D9/A 16574
  Complete submission text file 0001193125-23-000322.txt   18218
Mailing Address 202 CARNEGIE CENTER SUITE 106 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 106 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filed by) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 202 CARNEGIE CENTER SUITE 106 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 106 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Subject) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-91186 | Film No.: 23500500
SIC: 2836 Biological Products, (No Diagnostic Substances)